Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat.
Saved in:
| Title: | Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat. |
|---|---|
| Authors: | Gozzi, Alessandro, Herdon, Hugh, Schwarz, Adam, Bertani, Simone, Crestan, Valerio, Turrini, Giuliano, Bifone, Angelo |
| Source: | Psychopharmacology. Dec2008, Vol. 201 Issue 2, p273-284. 12p. 1 Color Photograph, 1 Diagram, 4 Graphs. |
| Subjects: | Physiological effects of methyl aspartate, Magnetic resonance imaging, Psychiatric drugs, Phencyclidine |
| Abstract: | Increasing experimental evidence suggests that impaired N-methyl- d-aspartic acid (NMDA) receptor (NMDAr) function could be a key pathophysiological determinant of schizophrenia. Agonists at the allosteric glycine (Gly) binding site of the NMDA complex can promote NMDAr activity, a strategy that could provide therapeutic efficacy for the disorder. NMDAr antagonists like phencyclidine (PCP) can induce psychotic and dissociative symptoms similar to those observed in schizophrenia and are therefore widely used experimentally to impair NMDA neurotransmission in vivo. In the present study, we used pharmacological magnetic resonance imaging (phMRI) to investigate the modulatory effects of endogenous and exogenous agonists at the NMDAr Gly site on the spatiotemporal patterns of brain activation induced by acute PCP challenge in the rat. The drugs investigated were d-serine, an endogenous agonist of the NMDAr Gly site, and SSR504734, a potent Gly transporter type 1 (GlyT-1) inhibitor that can potentiate NMDAr function by increasing synaptic levels of Gly. Acute administration of PCP induced robust and sustained activation of discrete cortico-limbo-thalamic circuits. Pretreatment with d-serine (1 g/kg) or SSR504734 (10 mg/kg) completely inhibited PCP-induced functional activation. This effect was accompanied by weak but sustained deactivation particularly in cortical areas. These findings suggest that agents that stimulate NMDAr via Gly co-agonist site can potentiate NMDAr activity in the living brain and corroborate the potential for this class of drugs to provide selective enhancement of NMDAr neurotransmission in schizophrenia. [ABSTRACT FROM AUTHOR] |
| Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 35261456 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gozzi%2C+Alessandro%22">Gozzi, Alessandro</searchLink><br /><searchLink fieldCode="AR" term="%22Herdon%2C+Hugh%22">Herdon, Hugh</searchLink><br /><searchLink fieldCode="AR" term="%22Schwarz%2C+Adam%22">Schwarz, Adam</searchLink><br /><searchLink fieldCode="AR" term="%22Bertani%2C+Simone%22">Bertani, Simone</searchLink><br /><searchLink fieldCode="AR" term="%22Crestan%2C+Valerio%22">Crestan, Valerio</searchLink><br /><searchLink fieldCode="AR" term="%22Turrini%2C+Giuliano%22">Turrini, Giuliano</searchLink><br /><searchLink fieldCode="AR" term="%22Bifone%2C+Angelo%22">Bifone, Angelo</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Psychopharmacology%22">Psychopharmacology</searchLink>. Dec2008, Vol. 201 Issue 2, p273-284. 12p. 1 Color Photograph, 1 Diagram, 4 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Physiological+effects+of+methyl+aspartate%22">Physiological effects of methyl aspartate</searchLink><br /><searchLink fieldCode="DE" term="%22Magnetic+resonance+imaging%22">Magnetic resonance imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatric+drugs%22">Psychiatric drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Phencyclidine%22">Phencyclidine</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Increasing experimental evidence suggests that impaired N-methyl- d-aspartic acid (NMDA) receptor (NMDAr) function could be a key pathophysiological determinant of schizophrenia. Agonists at the allosteric glycine (Gly) binding site of the NMDA complex can promote NMDAr activity, a strategy that could provide therapeutic efficacy for the disorder. NMDAr antagonists like phencyclidine (PCP) can induce psychotic and dissociative symptoms similar to those observed in schizophrenia and are therefore widely used experimentally to impair NMDA neurotransmission in vivo. In the present study, we used pharmacological magnetic resonance imaging (phMRI) to investigate the modulatory effects of endogenous and exogenous agonists at the NMDAr Gly site on the spatiotemporal patterns of brain activation induced by acute PCP challenge in the rat. The drugs investigated were d-serine, an endogenous agonist of the NMDAr Gly site, and SSR504734, a potent Gly transporter type 1 (GlyT-1) inhibitor that can potentiate NMDAr function by increasing synaptic levels of Gly. Acute administration of PCP induced robust and sustained activation of discrete cortico-limbo-thalamic circuits. Pretreatment with d-serine (1 g/kg) or SSR504734 (10 mg/kg) completely inhibited PCP-induced functional activation. This effect was accompanied by weak but sustained deactivation particularly in cortical areas. These findings suggest that agents that stimulate NMDAr via Gly co-agonist site can potentiate NMDAr activity in the living brain and corroborate the potential for this class of drugs to provide selective enhancement of NMDAr neurotransmission in schizophrenia. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=35261456 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00213-008-1271-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 273 Subjects: – SubjectFull: Physiological effects of methyl aspartate Type: general – SubjectFull: Magnetic resonance imaging Type: general – SubjectFull: Psychiatric drugs Type: general – SubjectFull: Phencyclidine Type: general Titles: – TitleFull: Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gozzi, Alessandro – PersonEntity: Name: NameFull: Herdon, Hugh – PersonEntity: Name: NameFull: Schwarz, Adam – PersonEntity: Name: NameFull: Bertani, Simone – PersonEntity: Name: NameFull: Crestan, Valerio – PersonEntity: Name: NameFull: Turrini, Giuliano – PersonEntity: Name: NameFull: Bifone, Angelo IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 12 Text: Dec2008 Type: published Y: 2008 Identifiers: – Type: issn-print Value: 00333158 Numbering: – Type: volume Value: 201 – Type: issue Value: 2 Titles: – TitleFull: Psychopharmacology Type: main |
| ResultId | 1 |